CERRAPINI LIMITED

Company Registration Number:
07999174 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

CERRAPINI LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2025

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

CERRAPINI LIMITED

Company Information

for the Period Ended 31 March 2025




Director: Heather Blake
Registered office: 2
Pegwell Road
Ramsgate
Kent
England
CT11 0HU
Company Registration Number: 07999174 (England and Wales)

CERRAPINI LIMITED

Balance sheet

As at 31 March 2025


Notes

2025
£

2024
£
Fixed assets
Tangible assets: 4 4,365 1,174
Total fixed assets: 4,365 1,174
Current assets
Stocks: 7,958 6,339
Debtors: 339 116
Cash at bank and in hand: 246 1,765
Total current assets: 8,543 8,220
Creditors: amounts falling due within one year: ( 18,753 ) ( 10,420 )
Net current assets (liabilities): ( 10,210 ) ( 2,200 )
Total assets less current liabilities: ( 5,845 ) ( 1,026 )
Total net assets (liabilities): ( 5,845 ) ( 1,026 )

The notes form part of these financial statements

CERRAPINI LIMITED

Balance sheet continued

As at 31 March 2025


Notes

2025
£

2024
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: ( 5,945 ) ( 1,126 )
Shareholders funds: ( 5,845 ) ( 1,026 )

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 24 June 2025
And Signed On Behalf Of The Board By:

Name: Heather Blake
Status: Director

The notes form part of these financial statements

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 2. Employees


    2025

    2024
    Average number of employees during the period 1 1

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

  • 3. Off balance sheet disclosure

    No

CERRAPINI LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2025

4. Tangible Assets

Total
Cost £
At 01 April 2024 7,703
Additions 5,666
Disposals -
Revaluations -
Transfers -
At 31 March 2025 13,369
Depreciation
At 01 April 2024 6,529
Charge for year 2,475
On disposals -
Other adjustments -
At 31 March 2025 9,004
Net book value
At 31 March 2025 4,365
At 31 March 2024 1,174

We choose not to claim AIA or Writing down allowances for this year.